Ken Griffin Lava Therapeutics Nv Call Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1.57 - $2.29 $8,949 - $13,053
-5,700 Reduced 45.24%
6,900 $11,000
Q2 2024

Aug 14, 2024
BUY
$1.8 - $3.37 $4,320 - $8,088
2,400 Added 23.53%
12,600 $22,000
Q1 2024

May 15, 2024
BUY
$1.53 - $4.03 $15,606 - $41,106
10,200 New
10,200 $33,000

Others Institutions Holding LVTX

# of Institutions
28
Shares Held
3.61M
Call Options Held
32.9K
Put Options Held
500
View Full List

About LAVA Therapeutics NV

LVTX Quotes by TradingView
  • Ticker LVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,797,700
  • Market Cap $25.5M
  • Description
  • LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...
More about LVTX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email